The global medical-grade TPU films market size was estimated at USD 246.4 million in 2024 and is projected to grow at a CAGR of 5.5% from 2025 to 2030. The market is driven by the rising demand for advanced medical devices, such as catheters and implants, owing to TPU's biocompatibility and durability. In addition, the increasing prevalence of chronic wounds and an aging population necessitating extended medical care are fueling market growth.
The medical-grade TPU films industry is significantly driven by the rising demand for advanced wound care products and medical devices. Thermoplastic polyurethane (TPU) films offer a unique combination of properties, such as biocompatibility, flexibility, high tensile strength, and excellent barrier resistance, which make them ideal for use in wound dressings, surgical drapes, ostomy bags, and catheter tubing. For example, advanced wound dressings, such as hydrocolloid and foam dressings, are increasingly incorporating TPU films to enhance moisture control and prevent bacterial infiltration. The growing prevalence of chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, is thus fueling the adoption of TPU films in the healthcare industry.
Medical-grade TPU films are soft, breathable, and skin-friendly, making them ideal for prolonged skin contact without causing irritation. Their ability to be used in breathable yet waterproof barriers has led to their adoption in products such as wearable biosensors and orthopedic braces. For example, companies are increasingly developing flexible wearable devices embedded with sensors that require a durable yet comfortable film layer, and TPU films meet these requirements efficiently. As healthcare delivery shifts toward remote patient monitoring and home-based care, the demand for such comfortable and functional materials is expected to grow.
Regulatory compliance and the need for sterilizable materials are also pivotal factors, contributing to the market growth. Medical-grade TPU films meet various international standards for medical applications, such as ISO 10993 for biocompatibility. These films can withstand sterilization processes such as gamma radiation and ethylene oxide (EtO) treatment without losing their mechanical integrity, which is crucial for surgical and diagnostic applications. Manufacturers in regions such as North America and Europe are particularly emphasizing the use of materials that comply with stringent regulatory requirements, boosting the demand for certified TPU films. In addition, their ease of processing through extrusion and lamination makes them a preferred choice among medical device manufacturers.
Moreover, sustainability and material innovation are emerging as influential growth drivers for the market. As the medical industry becomes more conscious of its environmental impact, TPU films are gaining traction for being eco-friendly compared to traditional PVC films, which release harmful substances during production and disposal. Many manufacturers are investing in the development of bio-based and recyclable TPU films to meet sustainability goals.
The polyether TPU films segment led the market with the largest revenue share of 45.92% in 2024. These films are widely used in medical applications due to their superior hydrolysis resistance, flexibility, and excellent biocompatibility. These films offer enhanced performance in moisture-prone environments, making them ideal for wound care products, surgical drapes, and implantable devices. Their ability to maintain elasticity and strength under prolonged exposure to bodily fluids makes them a preferred choice for sensitive medical applications.
The polyester TPU films segment is projected to grow at the fastest CAGR of 6.1% during the forecast period. These films are known for their high tensile strength, abrasion resistance, and excellent chemical resistance. These characteristics make them suitable for durable medical equipment, hospital bedding, and blood pressure cuffs. The primary drivers for polyester TPU films include the increasing demand for reusable medical equipment, cost-effective manufacturing materials, and enhanced chemical resistance in disinfectant-rich environments.
Based on application, the medical equipment segment led the market with the largest revenue share of 41.48% in 2024. These films are widely used in the manufacturing of medical equipment components such as tubing, catheters, blood bags, oxygen masks, and surgical drapes. The increasing demand for minimally invasive procedures and the growing number of surgeries globally are key drivers for this segment.
The wound dressing segment is projected to grow at the fastest CAGR of 6.4% during the forecast period. These films are commonly used as backing materials in wound care products, such as hydrocolloid dressings, transparent film dressings, and foam dressings. The growing prevalence of chronic wounds, such as diabetic ulcers and pressure sores, is driving demand for advanced wound care solutions.
The medical-grade TPU films market in North America is anticipated to grow at the fastest CAGR during the forecast period. The region's well-established healthcare infrastructure, substantial R&D investments, and stringent regulatory framework create an environment conducive to medical device innovation. North America's aging population has created significant demand for advanced wound care products, medical wearables, and implantable devices, all key application areas for medical-grade TPU films.
The medical-grade TPU films market in the U.S. growth can be attributed to its robust healthcare infrastructure and significant healthcare spending. With the country’s annual healthcare expenditure exceeding USD 4.5 trillion, U.S. medical facilities continually seek innovative materials such as TPU films for applications ranging from wound dressings to medical device components. Moreover, the rise in the aging population, the increase in chronic diseases, and the growth of home healthcare are also bolstering demand for medical-grade TPU films in the U.S.
Asia Pacific dominated the medical-grade TPU films marketwith the largest revenue share of 41.90% in 2024. It is anticipated to grow at the fastest CAGR of 6.2% over the forecast period. This dominance can be attributed to several interconnected factors, including the region's expanding healthcare infrastructure, growing medical device manufacturing capabilities, and increasing healthcare expenditures. Moreover, the region also benefits from a robust manufacturing ecosystem that has developed specialized expertise in TPU film production.
The China medical-grade TPU films market growthcan be attributed to its robust manufacturing infrastructure, combined with significant government investments in healthcare technology and medical device production. The country's strategic focus on healthcare innovation has been evident through initiatives such as "Made in China 2025" and the "Healthy China 2030" plan, which specifically targets medical materials advancement.
The medical-grade TPU films market in Europe is growing due to a combination of advanced healthcare infrastructure, stringent regulatory frameworks, and the concentrated presence of leading medical device manufacturers. Furthermore, Europe houses a significant concentration of specialized medical equipment manufacturers and pharmaceutical companies in hubs such as Germany, Switzerland, and the Nordic countries. This outlook creates demand for high volumes of quality medical consumables, thus increasing sustained demand for TPU films used in applications ranging from wound dressings to surgical drapes.
Medical-grade TPU films market in Germany is primarily driven by its robust manufacturing infrastructure and commitment to healthcare innovation. The country is home to some of the largest and most innovative medical technology companies in Europe, such as B. Braun, Fresenius, and Siemens Healthineers. These companies are major consumers of advanced materials like medical-grade TPU films
The competitive environment of the medical-grade TPU films industry is characterized by a mix of established multinational players and specialized manufacturers competing based on product performance, biocompatibility, regulatory compliance, and innovation. Mature players dominate the market with extensive R&D capabilities, diversified product portfolios, and strong distribution networks. Smaller regional players also contribute to price competitiveness and customization, particularly in emerging markets. Strategic collaborations, mergers, and a strong emphasis on sustainability and regulatory certifications are shaping the evolving competitive landscape.
The following are the leading companies in the medical-grade TPU films market. These companies collectively hold the largest market share and dictate industry trends.
In September 2024, Avient Corporation announced the expansion of its NEU Custom Capabilities and NEUSoft TPU manufacturing for catheter applications at its Suzhou, China facility, coinciding with its participation at Medtec China 2024. This expansion aims to better serve the growing medical materials demand in China and the Asia-Pacific region by improving response times and enabling closer collaboration with healthcare and medical device customers.
In October 2023, Covestro AG expanded its production capacity for TPU films in the Platilon range at its Bomlitz site in Lower Saxony, Germany, investing a low double-digit million-euro amount to meet rising global demand for multilayer TPU films used in automotive interiors, construction, wound care, and outdoor clothing.
Report Attribute |
Details |
Market size value in 2025 |
USD 259.5 million |
Revenue forecast in 2030 |
USD 339.8 million |
Growth rate |
CAGR of 5.5% from 2025 to 2030 |
Base year for estimation |
2024 |
Historical data |
2018 - 2023 |
Forecast period |
2025 - 2030 |
Quantitative units |
Revenue in USD million/billion, volume in tons, and CAGR from 2025 to 2030 |
Report coverage |
Revenue forecast, volume forecast, competitive landscape, growth factors, and trends |
Segments covered |
Product type, application, region |
Regional scope |
North America; Europe; Asia Pacific; Central & South America; Middle East & Africa |
Country scope |
U.S.; Canada; Mexico; Germany; France; UK; Italy; Spain; China; India; Japan; Australia; South Korea; Brazil; Argentina; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Permali Gloucester Ltd.; The Lubrizol Corporation; Singhal Industries Pvt. Ltd.; Covestro AG; Zhongshan Breathtex Speciality Material Co., Ltd.; Prochase Enterprise Co., Ltd.; UFP Technologies, Inc.; ARGOTEC; Wiman Corporation; AMERICAN POLYFILM, INC.; Avient Corporation |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional, and segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at a global level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global medical-grade TPU films market report based on product type, application, and region:
Product Type Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2030)
Polyether TPU Films
Polyester TPU Films
Others
Application Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2030)
Medical Equipment
Biomedical Products
Protective Suits
Wound Dressing
Others
Region Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Asia Pacific
China
India
Japan
South Korea
Australia
Central & South America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. The medical-grade TPU films market was estimated at around USD 246.4 million in the year 2024 and is expected to reach around USD 259.5 million in 2025.
b. The medical-grade TPU films market is expected to grow at a compound annual growth rate of 5.5% from 2025 to 2030 to reach around USD 339.8 million by 2030.
b. Medical equipment dominated the application segment of the market in 2024 with a 41.0% value share due to the rising demand for single-use, biocompatible devices and the surge in surgical procedures. The superior flexibility, durability, and chemical resistance of TPU films further boosted their adoption in critical medical components.
b. The key players in the medical-grade TPU films market include Permali Gloucester Ltd.; The Lubrizol Corporation; Singhal Industries Pvt. Ltd.; Covestro AG; Zhongshan Breathtex Speciality Material Co., Ltd.; Prochase Enterprise Co., Ltd.; UFP Technologies, Inc.; ARGOTEC; Wiman Corporation; AMERICAN POLYFILM, INC.; and Avient Corporation.
b. The medical-grade TPU films market is driven by increasing demand for biocompatible, flexible materials in advanced healthcare applications and the rise in chronic diseases and surgical procedures. Additionally, stringent hygiene regulations and the growth of single-use medical devices are accelerating market adoption.
NEED A CUSTOM REPORT?
We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.
Request CustomizationWe are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."